Did you miss our new episode of DoctoLIVE which took place on Monday 11th April, 2022? You can now fill in the form to get access to the recording! 👉
In this episode, our AplusA expert Karen Higginbottom was discussing with Dr Basu, an American academic genitouriary oncologist from UAB hospital, about what are the challenges in implementing new therapeutics in metastatic renal cell carcinoma in 2022. Get insight into the day-to-day of HCPs working in this area, uncover pain points and discover areas for improvement.
DoctoLIVE: A new opportunity to get answers to your questions directly from actual practitioners, all organized by AplusA
Why DoctoLIVE? 15 minutes of an HCP’s time booked by APLUSA to answer your practical questions, live.
DoctoLIVE is your window to real-world challenges in real-life healthcare practice, from an actual healthcare practioner's perspective.
DoctoLIVE offers you a 15-minute open-mic discussion featuring a different HCP every session, answering your questions related to real-life treatment experiences. These discussions will be held in English.
We will cover how to implement new therapeutics in actual practice, uncover pain points and discuss areas for improvement.
More about DoctoLIVE and previous episodes: DoctoLIVE by APLUSA
More on DLBCLsyndiTrack™ our syndicated survey about DLBCL with a CAR-T survey module: DLBCLsyndiTrack
More about APLUSA: Who we are